Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study
Research output: Contribution to journal › Journal article › Research › peer-review
To analyse the expression of the epidermal growth factor (EGF) system in prostate tissue and secretions obtained from patients with benign prostatic hyperplasia (BPH) treated with or without finasteride (which primarily targets the androgen-sensitive secretory epithelial cells in the prostate, with little effect on basal epithelial and stromal cells).
| Original language | English |
|---|---|
| Journal | B J U International (Print) |
| Volume | 89 |
| Issue number | 6 |
| Pages (from-to) | 583-90 |
| Number of pages | 8 |
| ISSN | 1464-4096 |
| Publication status | Published - 1 Apr 2002 |
- Epidermal Growth Factor, Finasteride, Glycoproteins, Growth Substances, Humans, Immunohistochemistry, Intercellular Signaling Peptides and Proteins, Male, Prospective Studies, Prostatic Hyperplasia, Receptor, Epidermal Growth Factor, Receptor, erbB-2, Transforming Growth Factor alpha
Research areas
ID: 33793156